Ngā hua rapu - Gordon Rustin
- E whakaatu ana i te 1 - 20 hua o te 40
- Haere ki te Whārangi Whai Ake
-
1
True mā Tim Meyer, Gordon Rustin
I whakaputaina 2000Revisão -
2
-
3
-
4
-
5
Reproducibility of dynamic contrast‐enhanced MRI in human muscle and tumours: comparison of quantitative and semi‐quantitative analysis mā Susan Galbraith, Martin A. Lodge, N. Jane Taylor, Gordon Rustin, Søren M. Bentzen, James Stirling, Anwar R. Padhani
I whakaputaina 2002Artigo -
6
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical researc... mā Graham M. Mead, M.H. Cullen, Robert Huddart, Peter Harper, Gordon Rustin, Pat Cook, Sally Stenning, Malcolm D. Mason
I whakaputaina 2005Artigo -
7
-
8
The efficacy of audiotapes in promoting psychological well-being in cancer patients: a randomised, controlled trial mā Patrick McHugh, Shôn Lewis, Sarah Ford, E.S. Newlands, Gordon Rustin, R. Charles Coombes, Dean Smith, Séamus O’Reilly, Lesley Fallowfield
I whakaputaina 1995Artigo -
9
Randomized Trial of Two or Five Computed Tomography Scans in the Surveillance of Patients With Stage I Nonseminomatous Germ Cell Tumors of the Testis: Medical Research Council Tria... mā Gordon Rustin, Graham M. Mead, Sally Stenning, P. Vasey, Nina Aass, Robert Huddart, M. Sokal, J. K. Joffe, Stephen Harland, S Kirk
I whakaputaina 2007Artigo -
10
-
11
-
12
5,6-Dimethylxanthenone-4-acetic acid (DMXAA), a novel antivascular agent: phase I clinical and pharmacokinetic study mā Gordon Rustin, Christopher Bradley, Susan Galbraith, M.R.L. Stratford, Paul M. Loadman, S. Waller, K Bellenger, Lindsey Gumbrell, Lisa K. Folkes, Gavin Halbert
I whakaputaina 2003Artigo -
13
Malignant Ovarian Germ Cell Tumors: Identification of Novel Prognostic Markers and Long-Term Outcome After Multimodality Treatment mā Nirupa Murugaesu, Peter Schmid, Gairin Dancey, Roshan Agarwal, L. Holden, Iain A. McNeish, Philip Savage, E.S. Newlands, Gordon Rustin, Michael J. Seckl
I whakaputaina 2006Artigo -
14
Use of CA-125 in Clinical Trial Evaluation of New Therapeutic Drugs for Ovarian Cancer mā Gordon Rustin, Robert C. Bast, Gary J. Kelloff, J. Carl Barrett, Stephen K. Carter, Perry D. Nisen, Caroline C. Sigman, David Parkinson, Raymond W. Ruddon
I whakaputaina 2004Revisão -
15
Comparison of CA-125 and Standard Definitions of Progression of Ovarian Cancer in the Intergroup Trial of Cisplatin and Paclitaxel Versus Cisplatin and Cyclophosphamide mā Gordon Rustin, P.J. Timmers, Ann E. Nelstrop, Gavin Shreeves, Søren M. Bentzen, Benoît Baron, Martine Piccart, K. Bertelsen, Gavin Stuart, James T. Cassidy, Elizabeth A. Eisenhauer
I whakaputaina 2005Artigo -
16
A Phase Ib trial of CA4P (combretastatin A-4 phosphate), carboplatin, and paclitaxel in patients with advanced cancer mā Gordon Rustin, Gavin Shreeves, Paul Nathan, Andrew Gaya, Trivadi S. Ganesan, D Wang, J Boxall, L. Poupard, David J. Chaplin, M.R.L. Stratford, Jai Balkissoon, Martin Zweifel
I whakaputaina 2010Artigo -
17
Low Molecular Weight Heparin, Therapy With Dalteparin, and Survival in Advanced Cancer: The Fragmin Advanced Malignancy Outcome Study (FAMOUS) mā Ajay K. Kakkar, Mark N. Levine, Zbigniew Kadziola, Nicholas R. Lemoine, V. Warren Low, Heman K. Patel, Gordon Rustin, Michael J. Thomas, Mary Quigley, R C N Williamson
I whakaputaina 2004Artigo -
18
Re: New Guidelines to Evaluate the Response to Treatment in Solid Tumors (Ovarian Cancer) mā Gordon Rustin, Michael Quinn, Tate Thigpen, Andreas du Bois, Éric Pujade-Lauraine, Anders Jakobsen, Elizabeth A. Eisenhauer, Satoru Sagae, Kathryn M. Greven, Ignace Vergote, Andrés Cervantes, Jan B. Vermorken
I whakaputaina 2004Carta -
19
Phase II trial of combretastatin A4 phosphate, carboplatin, and paclitaxel in patients with platinum-resistant ovarian cancer mā Martin Zweifel, Gordon C. Jayson, N.S. Reed, Richard H. Osborne, Bassam Abdul Rasool Hassan, Jonathan A. Ledermann, Gavin Shreeves, L. Poupard, S.-P. Lu, Jai Balkissoon, David J. Chaplin, Gordon Rustin
I whakaputaina 2011Artigo -
20
O6-Methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma mā MR Middleton, JM Lunn, C. Morris, Gordon Rustin, Stephen R. Wedge, MH Brampton, MJ Lind, Siow Ming Lee, David R. Newell, N M Bleehen, ES Newlands, A. Hilary Calvert, GP Margison, Nicholas Thatcher
I whakaputaina 1998Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Medicine
Internal medicine
Oncology
Chemotherapy
Cancer
Ovarian cancer
Biology
Pathology
Biochemistry
Surgery
Gene
Randomized controlled trial
Chemistry
Paleontology
Alternative medicine
Cisplatin
Clinical trial
Confidence interval
Germ cell tumors
Placebo
Stage (stratigraphy)
Gastroenterology
Hazard ratio
Olaparib
Poly ADP ribose polymerase
Polymerase
Gynecology
Pharmacology
Radiology
Adverse effect